Latest generation DES - What do I need to know?

Session comprising selected EuroPCR 2019 abstract submissions

Chairperson: O. Varenne
SHOW MORE

Summary

Consult this session to learn more about the latest generation drug-eluting stents, such as the dynamX novolimus-eluting bioadaptor, and discover the results of various clinical trials: ANGIOLITE, DIRECT II, and more! 

Presentations available when logged in:

  • DynamX novolimus-eluting bioadaptor - Engineering design and pre-clinical evaluation of an innovative device that adapts to patients' physiology, f...
  • Outcome of PCI with the Xience family everolimus-eluting stents compared with a pooled set of other commonly used modern DES: nationwide data from...
  • A prospective randomised multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subject...
  • The DIRECT II randomised, controlled study: final five-year follow-up
  • Five-year outcomes with newer-generation ultrathin-strut vs. thin-strut DES in patients undergoing percutaneous coronary revascularisation: a subgr...
  • Doctor! How long will my coronary artery stent last? Well, that depends! 10-year follow-up in the SORT-OUT II study
  • ANGIOLITE trial two-year follow-up. Non-inferiority randomised clinical trial comparing the efficacy and safety of Angiolite vs. Xience